AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2019
Feb 11, 2019
284_dirs_2019-02-11_63971d07-9308-4278-8c6d-e78554ed0409.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-02-08
Reporting Person: BRUN LESLIE A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-08 | Common Stock | M | 5000.0000 | $24.3000 | Acquired | 5000.0000 | Direct |
| 2019-02-08 | Common Stock | S | 3052.0000 | $77.2217 | Disposed | 1948.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-08 | Stock Option (right to buy) | $24.3000 | M | 5000.0000 | Disposed | 2019-04-30 | Common Stock (5000.0000) | Direct |
Footnotes
F1: The option became exercisable in equal installments on 05/01/2010, 05/01/2011 and 05/01/2012.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8